JPWO2021021830A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021021830A5
JPWO2021021830A5 JP2022506413A JP2022506413A JPWO2021021830A5 JP WO2021021830 A5 JPWO2021021830 A5 JP WO2021021830A5 JP 2022506413 A JP2022506413 A JP 2022506413A JP 2022506413 A JP2022506413 A JP 2022506413A JP WO2021021830 A5 JPWO2021021830 A5 JP WO2021021830A5
Authority
JP
Japan
Prior art keywords
seq
antibody
fragment
antibody fragment
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542699A5 (https=
JP2022542699A (ja
JP7667773B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/043908 external-priority patent/WO2021021830A1/en
Publication of JP2022542699A publication Critical patent/JP2022542699A/ja
Publication of JP2022542699A5 publication Critical patent/JP2022542699A5/ja
Publication of JPWO2021021830A5 publication Critical patent/JPWO2021021830A5/ja
Application granted granted Critical
Publication of JP7667773B2 publication Critical patent/JP7667773B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506413A 2019-07-29 2020-07-28 カンジダ属に対する抗体およびその使用法 Active JP7667773B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962879894P 2019-07-29 2019-07-29
US201962879912P 2019-07-29 2019-07-29
US62/879,894 2019-07-29
US62/879,912 2019-07-29
PCT/US2020/043908 WO2021021830A1 (en) 2019-07-29 2020-07-28 Antibodies to candida and uses thereof

Publications (4)

Publication Number Publication Date
JP2022542699A JP2022542699A (ja) 2022-10-06
JP2022542699A5 JP2022542699A5 (https=) 2023-06-20
JPWO2021021830A5 true JPWO2021021830A5 (https=) 2023-06-20
JP7667773B2 JP7667773B2 (ja) 2025-04-23

Family

ID=74230808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506413A Active JP7667773B2 (ja) 2019-07-29 2020-07-28 カンジダ属に対する抗体およびその使用法

Country Status (8)

Country Link
US (1) US20220280618A1 (https=)
EP (1) EP4007772A4 (https=)
JP (1) JP7667773B2 (https=)
KR (1) KR102822827B1 (https=)
CN (1) CN114901688A (https=)
AU (1) AU2020323925A1 (https=)
CA (1) CA3146123A1 (https=)
WO (1) WO2021021830A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115991752B (zh) * 2022-12-07 2025-10-31 中国科学技术大学 特定组氨酸甲基化修饰的pra1蛋白免疫原、多克隆抗体及应用
WO2025090760A1 (en) * 2023-10-25 2025-05-01 Board Of Regents, The University Of Texas System Antibodies specific to scube3 and methods of use
CN119930808B (zh) * 2025-01-09 2025-11-25 普健生物(武汉)科技有限公司 一种抗白念珠菌Csa2蛋白的单克隆抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2651575B2 (ja) * 1987-07-13 1997-09-10 神鋼電機株式会社 インバータの過電流検出装置
WO2000061637A1 (en) * 1999-04-14 2000-10-19 Smithkline Beecham Corporation Erythropoietin receptor antibodies
US20080148432A1 (en) * 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
GB0505489D0 (en) * 2005-03-18 2005-04-20 Domantis Ltd Antibodies
EP2102244A2 (en) * 2006-12-19 2009-09-23 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
WO2011035205A2 (en) 2009-09-18 2011-03-24 Calmune Corporation Antibodies against candida, collections thereof and methods of use
EP2699257A4 (en) 2011-04-21 2014-10-15 Univ Louisiana State PEPTIDE AND CONJUGATE VACCINES FOR FUNGI INFECTIONS
US10590178B2 (en) 2014-06-25 2020-03-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Chimeric vaccine against fungal infections
EP3277707A4 (en) * 2015-04-01 2018-08-08 Taipei Medical University Antibodies against infectious diseases
CN108368172B (zh) * 2015-07-15 2022-06-14 根马布股份公司 人源化或嵌合cd3抗体
WO2018237010A2 (en) * 2017-06-20 2018-12-27 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Vaccine compositions and methods of using the same

Similar Documents

Publication Publication Date Title
EP2087004A2 (en) A novel passive vaccine for candida infections
JP7288927B2 (ja) 乾癬性関節炎患者における構造的損傷の進行を阻害するためのil-17アンタゴニストの使用
AU2021240290A1 (en) Methods of treating non-radiographic axial spondyloarthritis using interleukin-17 (IL-17) Antagonists
CN111615519B (zh) 结合人il-5的单克隆抗体、其制备方法和用途
CN110624107A (zh) 通过施用il-4r拮抗剂治疗或预防哮喘的方法
JPWO2021021605A5 (https=)
WO2022033435A1 (zh) 一种抗冠状病毒的抗体及其应用
JPWO2021195418A5 (https=)
CN115515976A (zh) 冠状病毒抗体
CN108780091A (zh) 用于检测和治疗卵巢癌的组合物和方法
JP2024149479A (ja) 黄熱を処置するための方法および組成物
CN114621343A (zh) 乙型脑炎病毒抗体2g1及其应用
JPWO2021021830A5 (https=)
CN116655785A (zh) 一种抑制寨卡病毒感染的单克隆抗体及其应用
CN112552410A (zh) 一种抗体融合蛋白及其制法和在抗肿瘤中的应用
CN111153990B (zh) 针对Echo30的单克隆抗体、制备方法及其应用
CN111205366B (zh) 抗hpv45l1的单克隆中和抗体及其应用
RU2689326C1 (ru) Антиретровирусное лекарственное средство, нацеленное на эндогенный ретровирус человека
CN114605539A (zh) 人源化的抗IL-4Rα单域抗体及其应用
CN114773461B (zh) 乙型脑炎病毒抗体1d11及其应用
CN111205364B (zh) 抗hpv31l1的单克隆中和抗体及其应用
JP7171913B2 (ja) 化膿性汗腺炎の治療のための汎elr+cxcケモカイン抗体
JP2020518604A (ja) Il−17アンタゴニストを使用して喘息を選択的に治療する方法
JPWO2021101739A5 (https=)
WO2016118921A1 (en) Compositions and methods for treating psoriatic arthritis